COPD trials in Argentina

In Argentina 13 Also abroad 559

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
Where
Buenos Aires, La Plata, Mar del Plata, Mendoza
Age
30 years to 80 years
People
1,400 worldwide
Run by
AstraZeneca
See details and how to joinNCT07069829
Phase 2Taking people
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Where
Buenos Aires, Mendoza, Río Cuarto, Santa Rosa
Age
40 years to 75 years
People
606 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00
Phase 2Taking people
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Where
Alberdi, CABA, Ciudad Autónoma de Bs. As., Ciudad de Buenos Aires, Mar del Plata, Mendoza, Ranelagh, Rosario, San Miguel de Tucumán
Age
40 years and over
People
987 worldwide
Run by
AstraZeneca
See details and how to joinNCT07082738
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Berazategui, Buenos Aires, Córdoba, Mendoza, Santa Fe
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 2Taking people
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Where
Bahía Blanca, Buenos Aires, Córdoba, Mendoza, Quilmes, Rosario, San Miguel de Tucumán, Santa Fe
Age
40 years to 80 years
People
105 worldwide
Run by
Windward Bio
See details and how to joinNCT07646587
Phase 2/3Taking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Ciudad Autonoma de Buenos Aires, Córdoba, Mar del Plata, Mendoza, Rosario
Age
35 years to 80 years
People
1,156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
Phase 4Taking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
Buenos Aires, San Miguel de Tucumán
Age
40 years to 85 years
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Where
Buenos Aires, La Plata, Lobos, Rosario, San Miguel de Tucumán
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00
No phaseTaking people
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
Where
Buenos Aires, Medoza
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07245576
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Where
Alberdi, Buenos Aires, Ciudad de Buenos Aires, Florida, La Plata, Mar del Plata, Mendoza, Quilmes, Rosario, San Fernando, San Juan Bautista
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Where
Buenos Aires, Ciudad Autonoma de Bueno, La Plata, Mendoza, Paraná, Rosario, San Juan Bautista, San Miguel de Tucumán
Age
40 years to 80 years
People
981 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00
Phase 3Taking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Where
Berazategui, Buenos Aires, Córdoba, Lobos, Quilmes, Rosario, Rosario Provincia de Santa FE, San Miguel de Tucumán, Santa Fe, Sante Fe
Age
40 years to 80 years
People
961 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Buenos Aires, CABA, Ciudad Autónoma de Bs. As., Ciudad de Buenos Aires, Florida, Mar del Plata, Mendoza, Ranelagh, Rosario, San Fernando, San Juan Bautista, San Miguel de Tucumán
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00